QR kȏd

Biologic outcomes in patients with severe asthma and clinically relevant allergy in the CHRONICLE study

Background: Several mAb biologic therapies are approved for the treatment of severe asthma. There are limited data examining biologic outcomes in patients with allergy that has been clinically confirmed to exacerbate their asthma symptoms. Objective: Our aim was to assess rates of asthma exacerbatio...

Cijeli opis

Spremljeno u:
Glavni autori: Bradley E. Chipps, MD, Warner W. Carr, MD, Reynold A. Panettieri, Jr., MD, Weily Soong, MD, Jennifer Trevor, MD, Andrew W. Lindsley, MD, PhD, Christopher S. Ambrose, MD, MBA
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2026-01-01
Serija:Journal of Allergy and Clinical Immunology: Global
Teme:
Biologic
perennial allergy
efficacy
exacerbations
severe asthma
allergists
Online pristup:http://www.sciencedirect.com/science/article/pii/S2772829325001912
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti